08/05/2026
âī¸ āĻĢā§āϰā§āĻā§āύ āĻļā§āϞā§āĻĄāĻžāϰ (Adhesive Capsulitis):
āĻāĻŦā§āώāĻŖāĻž āĻ
āύā§āϝāĻžāϝāĻŧā§, āϏāĻžāϧāĻžāϰāĻŖ āĻāύāĻā§āώā§āĻ ā§āϤ⧠āĻāϰ āĻĒā§āϰāĻžāĻĻā§āϰā§āĻāĻžāĻŦ āĻĒā§āϰāĻžāϝāĻŧ ⧍âā§Ģ%, āĻāĻŋāύā§āϤ⧠Diabetes Mellitus āϰā§āĻā§āĻĻā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻāĻāĻŋ āĻŦā§āĻĄāĻŧā§ ā§§ā§Ļâā§Šā§Ļ% āĻĒāϰā§āϝāύā§āϤ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ āĻāĻāύ⧠āĻā§āĻŦā§āĻā§āύ āĻāĻ āĻāϞā§āϞā§āĻāϝā§āĻā§āϝ āĻŦā§āĻĻā§āϧāĻŋāϰ āĻāĻžāϰāĻŖ āĻā§?
âĒī¸ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻĒā§āϝāĻžāĻĨā§āĻĢāĻŋāĻāĻŋāĻāϞāĻāĻŋ: đđ
đĩ āĻā§āϞāĻžāĻā§āύā§āϰ āĻā§āϞāĻžāĻāĻā§āϏāĻžāĻāϞā§āĻļāύ (Glycosylation of collagen):
āĻĻā§āϰā§āĻāĻĻāĻŋāύ āϰāĻā§āϤ⧠āĻļāϰā§āĻāϰāĻžāϰ āĻŽāĻžāϤā§āϰāĻž āĻŦā§āĻļāĻŋ āĻĨāĻžāĻāϞ⧠Advanced Glycation End-products (AGEs) āϤā§āϰāĻŋ āĻšāϝāĻŧ, āϝāĻž āĻāϝāĻŧā§āύā§āĻ āĻā§āϝāĻžāĻĒāϏā§āϞ āĻ āϞāĻŋāĻāĻžāĻŽā§āύā§āĻā§ āĻāĻŽāĻž āĻšāϝāĻŧāĨ¤ āĻāϰ āĻĢāϞ⧠āĻāĻŋāϏā§āϝā§āϰ āύāĻŽāύā§āϝāĻŧāϤāĻž āĻāĻŽā§ āϝāĻžāϝāĻŧ āĻāĻŦāĻ āĻā§āϝāĻžāĻĒāϏā§āϞ āĻļāĻā§āϤ āĻ āĻĒā§āϰ⧠āĻšāϝāĻŧā§ āϝāĻžāϝāĻŧ
đĩ āĻĻā§āϰā§āĻāϏā§āĻĨāĻžāϝāĻŧā§ āύāĻŋāĻŽā§āύāĻŽāĻžāϤā§āϰāĻžāϰ āĻĒā§āϰāĻĻāĻžāĻš (Chronic low-grade inflammation):
āĻĄāĻžāϝāĻŧāĻžāĻŦā§āĻāĻŋāϏ āϰā§āĻā§āĻĻā§āϰ āĻļāϰā§āϰ⧠TNF-Îą āĻāĻŦāĻ IL-6āĻāϰ āĻŽāϤ⧠āĻĒā§āϰāĻĻāĻžāĻšāĻāύāĻŋāϤ āϏāĻžāĻāĻā§āĻāĻžāĻāύ āĻŦā§āĻļāĻŋ āĻĨāĻžāĻā§, āϝāĻž āĻāϝāĻŧā§āύā§āĻ āĻā§āϝāĻžāĻĒāϏā§āϞ⧠āĻĒā§āϰāĻĻāĻžāĻš āĻ āĻĢāĻžāĻāĻŦā§āϰā§āϏāĻŋāϏ āϏā§āώā§āĻāĻŋ āĻāϰā§
đĩ āĻŽāĻžāĻāĻā§āϰā§āĻāĻžāϏāĻā§āϞāĻžāϰ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ (Microvascular changes):
āĻā§āώā§āĻĻā§āϰ āϰāĻā§āϤāύāĻžāϞā§āϰ āϏāĻŽāϏā§āϝāĻž (microangiopathy) āĻāĻŋāϏā§āϝā§āϰ āĻĒā§āώā§āĻāĻŋ āĻ āϰāĻā§āϤ āϏāϰāĻŦāϰāĻžāĻš āĻāĻŽāĻŋāϝāĻŧā§ āĻĻā§āϝāĻŧ, āĻĢāϞ⧠āĻāĻŋāϏā§āϝ⧠āĻšāĻŋāϞāĻŋāĻ āĻāĻŽā§ āϝāĻžāϝāĻŧ āĻāĻŦāĻ āĻāϝāĻŧā§āύā§āĻ āĻļāĻā§āϤ āĻšāϝāĻŧā§ āϝāĻžāϝāĻŧ
đĩ āĻĢāĻžāĻāĻŦā§āϰā§āĻŦā§āϞāĻžāϏā§āĻā§āϰ āĻāĻžāϰā§āϝāĻāĻžāϰāĻŋāϤāĻžāϰ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ (Altered fibroblast activity):
āĻĄāĻžāϝāĻŧāĻžāĻŦā§āĻāĻŋāϏ āϰā§āĻā§āĻĻā§āϰ āĻĢāĻžāĻāĻŦā§āϰā§āĻŦā§āϞāĻžāϏā§āĻ āĻŦā§āĻļāĻŋ āĻļāĻā§āϤ (non-elastic) āĻā§āϞāĻžāĻā§āύ āϤā§āϰāĻŋ āĻāϰā§, āϝāĻžāϰ āĻĢāϞ⧠āĻāϝāĻŧā§āύā§āĻ āĻā§āϝāĻžāĻĒāϏā§āϞ āĻĒā§āϰ⧠āĻšāϝāĻŧ āĻāĻŦāĻ āĻŽā§āĻāĻŽā§āύā§āĻ āϏā§āĻŽāĻŋāϤ āĻšāϝāĻŧā§ āϝāĻžāϝāĻŧ
đ āĻāĻ āϏāĻŦ āĻāĻžāϰāĻŖ āĻāĻāϏāĻžāĻĨā§ āĻŽāĻŋāϞā§āĻ āĻĄāĻžāϝāĻŧāĻžāĻŦā§āĻāĻŋāϏ āϰā§āĻā§āĻĻā§āϰ āĻŽāϧā§āϝ⧠āĻĢā§āϰā§āĻā§āύ āĻļā§āϞā§āĻĄāĻžāϰ āĻŦā§āĻļāĻŋ āĻĻā§āĻāĻž āϝāĻžāϝāĻŧ āĻāĻŦāĻ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻŦā§āĻļāĻŋ āĻā§āϰā§āϤāϰ āĻšāϝāĻŧāĨ¤
âī¸ Frozen Shoulder (Adhesive Capsulitis):
According to studies, its prevalence ranges from 2â5% in the general population, but in patients with Diabetes Mellitus, it rises significantly to 10â30%. Have you ever wondered why this noticeable increase occurs? đ§
âĒī¸ Possible Pathophysiology: đđ
đĩ Glycosylation of collagen:
Chronic high blood sugar leads to the formation of Advanced Glycation End-products (AGEs), which accumulate in the joint capsule and ligaments. This reduces elasticity and increases capsular stiffness
đĩ Chronic low-grade inflammation:
Diabetic patients have higher levels of inflammatory cytokines such as TNF-Îą and IL-6, which contribute to capsular inflammation and fibrosis
đĩ Microvascular changes:
Impaired microcirculation (microangiopathy) reduces tissue nutrition and healing capacity, contributing to joint stiffness
đĩ Altered fibroblast activity:
Fibroblasts in diabetic patients produce more rigid collagen, leading to thickening of the joint capsule and restriction of range of motion
đ All these mechanisms together explain why frozen shoulder is more common and often more severe in diabetic patients.